By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

pSivida Corp 

400 Pleasant Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-926-5000 Fax: 617-926-5050


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Leading Retinal Specialists To Highlight pSivida (PSDV)’s Durasert For Treatment Of Posterior Segment Uveitis At Prestigious Ophthalmology Conferences 7/18/2017 10:44:36 AM
pSivida (PSDV) Enhances Board Of Directors With Election Of Veteran Healthcare Executive Kristine Peterson 6/28/2017 10:04:56 AM
pSivida (PSDV) Submits Marketing Authorization Application (MAA) For Approval Of Durasert Three-Year Treatment For Posterior Segment Uveitis In The European Union 6/22/2017 11:19:28 AM
pSivida (PSDV)'s Eye Drug/Device Hits Goals In Second Late-Stage Study 6/13/2017 7:03:26 AM
pSivida (PSDV) Release; Durasert Three-Year Treatment For Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months 5/8/2017 9:00:27 AM
pSivida (PSDV) Reports Fiscal 2017 Third Quarter Results; Key Milestones On Track 5/5/2017 11:15:50 AM
pSivida (PSDV) To Report Third Quarter Fiscal Year 2017 Financial Results On Thursday, May 4th 4/20/2017 10:33:06 AM
pSivida (PSDV) To Present At The Ladenburg Thalmann Annual Healthcare Conference 9/22/2016 8:59:38 AM
Primary Endpoint Met in pSivida (PSDV)’s First Medidur Phase III 8/16/2016 7:48:23 AM
pSivida (PSDV) And Hospital For Special Surgery Innovation Center Announce Opening Of IND For Sustained-Release Implant For Severe Knee Osteoarthritis 8/2/2016 8:02:52 AM
12345678910...
//-->